Prototypicaldopamineagonist(pKivaluesare6.43,7.08,7.59,8.36and7.83forhumanrecombinantD1,D2L,D3,D4andD5receptorsrespectively).Producesbiphasiceffectsonlocomotoractivity,anddisplaysanti-Parkinsonianandneuroprotectiveactionsfollowingsystemicadministrationinvivo.
| M.Wt | 303.79 |
| Formula | C17H17NO2.HCl |
| Storage | StoreatRT |
| Purity | ≥99%(HPLC) |
| CASNumber | 314-19-2 |
| PubChemID | 9410 |
| InChIKey | SKYZYDSNJIOXRL-BTQNPOSSSA-N |
| Smiles | OC1=C2C(C[C@]4([H])C3=C2C=CC=C3CCN4C)=CC=C1O.Cl |
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
| Solvent | MaxConc.mg/mL | MaxConc.mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 30.38 | 100 | |
| water | 13.37 | 50 |
Thefollowingdataisbasedontheproductmolecularweight303.79.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.
| Concentration/SolventVolume/Mass | 1mg | 5mg | 10mg |
|---|---|---|---|
| 1mM | 3.29mL | 16.46mL | 32.92mL |
| 5mM | 0.66mL | 3.29mL | 6.58mL |
| 10mM | 0.33mL | 1.65mL | 3.29mL |
| 50mM | 0.07mL | 0.33mL | 0.66mL |



